↓ Skip to main content

CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway

Overview of attention for article published in Clinical Epigenetics, September 2018
Altmetric Badge

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
80 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway
Published in
Clinical Epigenetics, September 2018
DOI 10.1186/s13148-018-0548-2
Pubmed ID
Authors

Janina Graule, Kristin Uth, Elia Fischer, Irene Centeno, José A. Galván, Micha Eichmann, Tilman T. Rau, Rupert Langer, Heather Dawson, Ulrich Nitsche, Peter Traeger, Martin D. Berger, Beat Schnüriger, Marion Hädrich, Peter Studer, Daniel Inderbitzin, Alessandro Lugli, Mario P. Tschan, Inti Zlobec

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 80 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 19%
Researcher 13 16%
Other 8 10%
Student > Doctoral Student 5 6%
Student > Master 5 6%
Other 11 14%
Unknown 23 29%
Readers by discipline Count As %
Medicine and Dentistry 17 21%
Biochemistry, Genetics and Molecular Biology 13 16%
Agricultural and Biological Sciences 6 8%
Immunology and Microbiology 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 9 11%
Unknown 29 36%